# TYENNE

NDC: 65219-586
Generic name: Tocilizumab-aazg
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20240701

FDA application: BLA761275

## Active ingredients

- TOCILIZUMAB: 162 mg/.9mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"65219-586"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=65219-586
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ad76441d-da59-47df-8d9d-2243005180f0